All Stories

  1. Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting β2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan

    Article • International Journal of Chronic Obstructive Pulmonary Disease, October 2018, Dove Medical Press

    Nobuyuki Hizawa

  2. The distribution of blood eosinophil levels in a Japanese COPD clinical trial database and in the rest of the world

    Article • International Journal of Chronic Obstructive Pulmonary Disease, February 2018, Dove Medical Press

    Nobuyuki Hizawa

  3. A case of a pulmonary artery sling misdiagnosed as refractory asthma for 20 years

    Article • Clinical Case Reports, April 2017, Wiley

    Nobuyuki Hizawa

  4. Clinical approaches towards asthma and chronic obstructive pulmonary disease based on the heterogeneity of disease pathogenesis

    Article • Clinical & Experimental Allergy, April 2016, Wiley

    Nobuyuki Hizawa

  5. A comprehensive assessment using COPD assessment test scoring and modified Medical Research Council dyspnea scoring is necessary for personalized therapy for COPD patients

    Article • International Journal of Chronic Obstructive Pulmonary Disease, October 2015, Dove Medical Press

    Nobuyuki Hizawa

  6. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes

    Article • International Journal of Chronic Obstructive Pulmonary Disease, June 2015, Dove Medical Press

    Nobuyuki Hizawa

  7. The search for common pathways underlying asthma and COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, January 2013, Taylor & Francis

    Hiroaki Iijima, Nobuyuki Hizawa

  8. Lower FEV1 in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV1, total IgE levels, and TSLP genotypes

    Article • International Journal of Chronic Obstructive Pulmonary Disease, March 2011, Taylor & Francis

    Hiroaki Iijima, Nobuyuki Hizawa